Applications of Methyl 3-Amino-5,6-Dichloro-2-Pyrazinecarboxylate in Industrial Manufacturing

Methyl 3-Amino-5,6-Dichloro-2-Pyrazinecarboxylate serves specialized roles in regulated pharmaceutical intermediates, crop protection active ingredient synthesis, advanced chemical research, and veterinary drug precursor production. As a core manufacturer, our supply meets high demand in these downstream segments, with technical support aligned to industry protocols and quality control systems, ensuring stable and safe integration into users’ proprietary formulations and processes.

1. Pharmaceutical Intermediate for Anti-Tuberculosis Drug Synthesis

In pharmaceutical API manufacturing, this compound acts as an essential intermediate for synthesizing pyrazine-based anti-tuberculosis agents. Production sites use it at controlled stages for high-value intermediates, following process validation and batch-level quality documentation. This role demands narrow impurity profiles and secure supply chains, supporting global regulatory filings and finished pharmaceutical production.

Industry compliance standards

• ICH Q7 GMP for active pharmaceutical ingredient production
• European Pharmacopoeia (EP) and United States Pharmacopeia (USP) requirements for impurities and residual solvents
• FDA 21 CFR Parts 210/211 for pharmaceutical manufacturing processes
• WHO GMP for export markets including Southeast Asia and Africa

Typical usage ratio

• Batch input range: 1.2 to 1.7 molar equivalents per finished API unit
• Exact input adjusted based on route yield and in-process control results

Downstream process integration

• Charged as a key condensation intermediate after initial pyrazine ring functionalization
• Undergoes specific amination and acylation under controlled temperature and pH
• Integrated with in-line HPLC monitoring for impurity tracking

Final product types

• Active pharmaceutical ingredients for anti-tuberculosis therapies
• Amino-pyrazine derivatives for fixed-dose combination drugs
• Regulatory-approved intermediates for bulk API supply to finished formulation plants

2. Synthesis of Herbicidal Pyrazine Derivatives in Agrochemical Manufacturing

The material supports synthesis of specialty pyrazine compounds used as herbicide actives. Agrochemical formulators require high purity levels and solvent compatibility. It acts as a nucleophile in step-growth polymerization or heterocycle coupling, enabling downstream conversion to field-ready agrochemicals. Production lines implement precise ratio control and traceability batches for compliance and trace impurity minimization.

Industry compliance standards

• FAO/WHO Pesticide Specifications (JMPS)
• ISO 9001:2015 certified quality systems for raw material traceability
• REACH Regulation (EC) No 1907/2006 for registration in EU plant protection
• Chinese GB 2763-2021 Maximum Residue Limits for Pesticides

Typical usage ratio

• Applied at 0.5–1.1 molar equivalents depending on target herbicide structure
• Input quantity refined by targeted herbicidal mechanism and downstream stability

Downstream process integration

• Introduced during initial reactor loading as a monomer unit for pyrazine backbone construction
• Subjected to chlorination or methylation before coupling with sulfonylurea or imidazolinone intermediates
• Integrated within in-situ solvent recycling protocols for EHS compliance

Final product types

• Pyrazine-based herbicidal actives for pre- and post-emergence weed control
• Formulated suspension concentrates (SCs) and water dispersible granules (WDGs)
• Export-grade technical concentrates for toll formulation partners

3. Chemical Research Reagent for Heterocyclic Compound Development

Research institutes and pilot plants use this compound for exploring new pyrazine-based heterocyclic scaffolds. It proves valuable in high-throughput screening, structure-activity optimization, and analytical standards preparation. Researchers prefer controlled impurity levels and well-documented quality parameters. Integration occurs in parallel syntheses and combinatorial chemistry applications under tightly monitored lab conditions.

Industry compliance standards

• GLP (Good Laboratory Practice) for research reagent material sourcing
• Local laboratory chemical safety regulations and inventory tracking
• ISO/IEC 17025:2017 accreditation for analytical laboratories
• HS Classification 29339990 for regulated shipment

Typical usage ratio

• Input ranges from 0.05 to 0.5 mmol per screening reaction
• Dosage scaled with batch size and assay requirements in process development

Downstream process integration

• Used as a starting block in solution-phase or solid-phase synthesis matrices
• Incorporated during fragment-based lead optimization cycles
• Integrated into automated synthesis robots or microreactor cartridges

Final product types

• Novel pyrazine analogues for pharmaceutical screening
• Reference standards for analytical method development
• Small-molecule tool compounds for biological assay systems

4. Veterinary Drug Intermediate for Antibacterial Agent Production

Animal health manufacturers apply this precursor in the preparation of veterinary antibacterial APIs and related feed additive compounds. The input requires pharmaceutical-grade traceability, and batch consistency supports efficient regulatory filings. Use depends on the product’s chain length, with multi-step synthesis tracked to ensure impurity carryover remains below veterinary-pharma acceptance criteria.

Industry compliance standards

• VICH GLs (International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products)
• China Veterinary Pharmacopoeia (CVP) for animal drug substances
• European Medicines Agency (EMA) requirements for veterinary substance registration
• CMP Quality Management for feed additive ingredients

Typical usage ratio

• Generally used at 0.7–1.3 molar equivalents in multi-step antibiotic precursor synthesis
• Adjusted in process scale-up based on batch yields and regulatory impurity limits

Downstream process integration

• Reacted during the N-alkylation or cyclization steps for targeted antibacterial activity
• Integrated into process streams with isolated intermediate purification
• Subjected to solid-phase or solution-phase separation for high-purity veterinary APIs

Final product types

• Veterinary antibacterial API powders
• Premix ingredients for medicated animal feeds
• Finished dosage formulations such as bolus, suspensions, and oral pastes